Literature DB >> 2928473

The relationship of increased nuclear protein content induced by hyperthermia to killing of HeLa S3 cells.

H H Kampinga1, N Turkel-Uygur, J L Roti Roti, A W Konings.   

Abstract

The role of a heat-induced increase in nuclear protein mass in killing of cells by hyperthermia was investigated jointly by two groups that had previously reported apparently conflicting results. A correlation between the fraction of HeLa S3 cells killed and the protein content of nuclei isolated immediately after heat exposure was found. This correlation held when thermal sensitivity was modified by the sensitizers 0.41 M ethanol and 5 mM procaine or by the protector 0.6 M glycerol. However, when the HeLa cells were made thermotolerant by a priming heat exposure of 15 min at 45 degrees C followed by 5 h at 37 degrees C, the correlation no longer held. At the 10% survival level a 1.27-fold greater nuclear protein content was observed in tolerant cells relative to nontolerant cells. Thus no general correlation between initial heat-induced nuclear protein mass changes and hyperthermic cell killing exists. When heated cells were returned to 37 degrees C, a time-dependent reduction in the protein content was observed in nuclei isolated after incubation for various times at 37 degrees C. This rate of reduction in nuclear protein content was found to be accelerated in the tolerant cells. Heat-induced changes in cell-cycle progression had no significant effects on the data obtained. It is concluded from the total data base that not only the absolute increment in nuclear protein mass must be taken into account but also the duration of the binding expressed in the rate of recovery.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2928473

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  8 in total

1.  Stress protection by a fluorescent Hsp27 chimera that is independent of nuclear translocation or multimeric dissociation.

Authors:  Michael J Borrelli; Laura J Bernock; Jacques Landry; Douglas R Spitz; Lee A Weber; Eileen Hickey; Michael L Freeman; Peter M Corry
Journal:  Cell Stress Chaperones       Date:  2002-07       Impact factor: 3.667

2.  Kadota Fund International Forum 2004. Application of thermal stress for the improvement of health, 15-18 June 2004, Awaji Yumebutai International Conference Center, Awaji Island, Hyogo, Japan. Final report.

Authors:  Tsutomu Sugahara; J van der Zee; Harm H Kampinga; Zeliko Vujaskovic; Motoharu Kondo; Takeo Ohnishi; Gloria Li; Heon J Park; Dennis B Leeper; Valentina Ostapenko; Elizabeth A Repasky; Masami Watanabe; Chang W Song
Journal:  Int J Hyperthermia       Date:  2008-03       Impact factor: 3.914

3.  The nuclear matrix is a thermolabile cellular structure.

Authors:  J R Lepock; H E Frey; M L Heynen; G A Senisterra; R L Warters
Journal:  Cell Stress Chaperones       Date:  2001-04       Impact factor: 3.667

4.  In vivo chaperone activity of heat shock protein 70 and thermotolerance.

Authors:  E A Nollen; J F Brunsting; H Roelofsen; L A Weber; H H Kampinga
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 5.  [Principles, technology and indication of hyperthermia and part body hyperthermia].

Authors:  M Schlemmer; L H Lindner; S Abdel-Rahman; R D Issels
Journal:  Radiologe       Date:  2004-04       Impact factor: 0.635

6.  The cellular heat shock response monitored by chemical exchange saturation transfer MRI.

Authors:  Dennis Kleimaier; Steffen Goerke; Cordula Nies; Moritz Zaiss; Patrick Kunz; Peter Bachert; Mark E Ladd; Eric Gottwald; Lothar R Schad
Journal:  Sci Rep       Date:  2020-07-06       Impact factor: 4.379

7.  Cisplatin sensitivity and thermochemosensitisation in thermotolerant cDDP-sensitive and -resistant cell lines.

Authors:  J V Hettinga; W Lemstra; A W Konings; H H Kampinga
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

8.  Hyperthermia, thermotolerance and topoisomerase II inhibitors.

Authors:  H H Kampinga
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.